Joel M. Neutel

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers et al. · JAMA · 2014 · 492 citations

Anti-PCSK9 Monotherapy for Hypercholesterolemia

Michael J. Koren, Pernille Lundqvist, Michael A. Bolognese et al. · Journal of the American College of Cardiology · 2014 · 399 citations

Lipid Disorder, Anti-pcsk9 Monotherapy, Cardiovascular Disease +6

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

Michael A. Weber, Joel M. Neutel, David H.G. Smith · Journal of the American College of Cardiology · 2001 · 122 citations

Obesity, Hypertension, Physical Activity +14

Implications of a Health Lifestyle and Medication Analysis for Improving Hypertension Control

Edward Maibach, George L. Bakris, H BLACK et al. · Archives of Internal Medicine · 2000 · 115 citations

A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide

Willa A. Hsueh, Shawna D. Nesbitt, Thomas J. Littlejohn et al. · Journal of Clinical Hypertension · 2011 · 83 citations · Full text